微轴流 (Impella CP®) 在患有ST升高心肌梗塞的患者中,由心脏性冲击复杂化
Rasmus Paulin Beske1, Christian Juhl Terkelsen2, Andreas Schäfer3
1Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Kardiologia polska
|August 14, 2024
概括
丹格尔Shock试验发现,Impella CP®机械循环支持显著降低了ST升高心肌梗塞患有心脏性休克的患者的死亡率,改善了生存结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 带有心脏性休克的ST升高心肌梗塞 (STEMI) 的死亡率很高.
- 目前的重血管化技术对这些重症患者的存活率提供了有限的改善.
- 机械循环支持 (MCS) 设备正在成为一种潜在的治疗选择.
研究的目的:
- 为了评估Impella CP®微轴流量除了标准护理之外的有效性,而不是仅仅标准护理.
- 确定Impella CP®对心脏性休克STEMI患者的生存结果的影响.
- 评估与Impella CP®在这个人群中的使用相关的安全性和不良事件.
主要方法:
- 丹格尔冲击试验是一项随机对照试验.
- 由于心脏性休克而复杂的STEMI患者被随机分配到接受Impella CP®加标准护理或仅接受标准护理.
- 主要终点是90天内全因死亡率.
主要成果:
- 与标准护理组相比,Impella CP®组显示90天死亡率显著降低.
- 虽然Impella CP®手臂出现了增加不良事件的趋势,但生存益处很大.
- 该设备有效地改善了心脏输出和全身输液.
结论:
- 伊佩拉CP®机械循环支持显著改善了STEMI和心脏性休克患者的生存率.
- 伊佩拉CP®的好处超过了潜在的风险,提供了一个重要的治疗选择.
- 需要进一步的研究来优化患者的选择,并尽量减少与设备相关的并发症.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


